Abbott India continues its northward journey on stellar Q2 earnings

Abbott India is currently trading at Rs. 1549.50, up by 8.05 points or 0.52% from its previous closing of Rs. 1541.45 on the BSE.

The scrip opened at Rs. 1559.95 and has touched a high and low of Rs. 1560.00 and Rs. 1542.35 respectively. So far 316 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1807.00 on 16-Apr-2012 and a 52 week low of Rs. 1375.05 on 01-Jun-2012.

Last one week high and low of the scrip stood at Rs. 1598.95 and Rs. 1499.00 respectively. The current market cap of the company is Rs. 3280.89 crore.

The promoters holding in the company stood at 74.99% while Institutions and Non-Institutions held 5.84% and 19.18% respectively.

Abbott India has reported results for second quarter ended June 30, 2012.

The company has reported a rise of 72.63% in its net profit at Rs 29.52 crore for the quarter under review as compared to Rs 17.10 crore for the same quarter in the previous year. The total income from operation of the company has increased by 14.20% at Rs 411.82 crore for Q2FY13 as compared Rs 360.62 crore for the corresponding quarter previous year.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services. In 1888 a young Chicago physician, Dr Wallace Calvin Abbott founded Abbott Laboratories.